| First Author | Imanishi M | Year | 2016 |
| Journal | Arterioscler Thromb Vasc Biol | Volume | 36 |
| Issue | 11 | Pages | 2158-2162 |
| PubMed ID | 27562915 | Mgi Jnum | J:249233 |
| Mgi Id | MGI:6094747 | Doi | 10.1161/ATVBAHA.116.307784 |
| Citation | Imanishi M, et al. (2016) Hypoxia-Inducible Factor-1alpha in Smooth Muscle Cells Protects Against Aortic Aneurysms-Brief Report. Arterioscler Thromb Vasc Biol 36(11):2158-2162 |
| abstractText | OBJECTIVE: The purpose of this study was to determine the role of smooth muscle cell-derived hypoxia-inducible factor-1alpha (Hif-1alpha) in the pathogenesis of aortic aneurysms. APPROACH AND RESULTS: Control mice and smooth muscle cell-specific hypoxia-inducible factor-1alpha-deficient mice were infused with beta-aminopropionitrile for 2 weeks and angiotensin II for 6 weeks to induce aortic aneurysm formation. Mutant mice experienced increased levels of aneurysm formation of the thoracic or abdominal aorta with more severe elastin disruption, compared with control mice. Smooth muscle cell-specific hypoxia-inducible factor-1alpha deficiency did not affect matrix metalloproteinase-2 activity; however, the activity of lysyl oxidase and the levels of tropoelastin mRNA in the angiotensin II- and beta-aminopropionitrile-treated aortae, associated with elastin fiber formation, were suppressed. Furthermore, we observed reduced volumes of mature cross-linked elastin in the thoracoabdominal aorta after treatment with angiotensin II and beta-aminopropionitrile. CONCLUSIONS: Deficiency of smooth muscle cell-derived hypoxia-inducible factor-1alpha augments aortic aneurysms, accompanied by disruption of elastin fiber formation, but not changes of elastin fiber degradation. |
